Association of interferon γ T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 92, Issue 1, 2007, Pages

  Bokodi, G ^a   Derzbach, L ^a   Banyasz I ^a   Tulassay, T ^b   Vasarhelyi B ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40;

ALLELE; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; HETEROZYGOTE DETECTION; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INFANT; LOGISTIC REGRESSION ANALYSIS; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTERITIS; NEWBORN; NEWBORN DISEASE; OXYGENATION; PATENT DUCTUS ARTERIOSUS; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; BRONCHOPULMONARY DYSPLASIA; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, NECROTIZING; FEMALE; GENOTYPE; GESTATIONAL AGE; HUMANS; HYPOTENSION; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-12 SUBUNIT P40; MALE; PNEUMONIA; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33846337879     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2005.086421     Document Type: Article

References (36)

1. Bourbon J, Boucherat O, Chailley-Heu B, et al. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 2005;57:R38-46.
2. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9.
3. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003;8:29-38.
4. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001;160:457-63.
5. Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate 2003;84:297-303.
6. Jones CA, Warner JO. Regulating a regulator: IFNgamma production by the neonate. Clin Exp Allergy 1999;29:865-8.
7. Marodi L. IL-12 and IFN-gamma deficiencies in human neonates. Pediatr Res 2001;49:316.
8. h1 responses in human neonates. Clin Exp Immunol 2002;128:1-2.
9. Gessani S, Belardelli F. IFN-gamma expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev 1998;9:117-23.
10. Pestka S, Krouse CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004;202:8-32.
11. Watford WT, Moriguchi M, Morinobu A, et al. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003;14:361-8.
12. Dembinski J, Behrendt D, Martini R, et al. Modulation of pro- and anti-inflammatory cytokine production in very preterm infants. Cytokine 2003;21:200-6.
13. Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:863-6.
14. Warle MC, Farhan A, Metselaar HJ, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003;9:170-81.
15. Huang D, Cancilia MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000;1:515-20.
16. Morahan G, Huang D, Wu M, et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children [correction appears in Lancet 2002;360:1892]. Lancet 2002;360:455-9.
17. Morahan G, Boutlis CS, Huang D, et al. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun 2002;3:414-18.
18. Heep A, Schueller AC, Kattner E, et al. Association of two tumour necrosis factor gene polymorphisms with the incidence of severe intraventricular haemorrhage in preterm infants. J Med Genet 2005;42:604-8.
19. Annells MF, Hart PH, Mullighan CG, et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004;191:2056-67.
20. Amory JH, Adams KM, Lin MT, et al. Adverse outcomes after preterm labor are associated with tumor necrosis factor-alpha polymorphism-863, but not-308, in mother-infant pairs. Am J Obstet Gynecol 2004;191:1362-7.
21. Kazzi SN, Kim UO, Quasney MW, et al. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004;114:e243-8.
22. Bokodi G, Treszl A, Derzbach L, et al. The association of the carrier state of the tumor necrosis factor-alpha (TNFalpha)-308A allele with the duration of oxygen supplementation in preterm neonates. Eur Cytokine Netw 2005;16:78-80.
23. Khoo SK, Hayden CM, Roberts M, et al. Associations of the IL12B promoter polymorphism in longitudinal data from asthmatic patients 7 to 42 years of age. J Allergy Clin Immunol 2004;113:475-81.
24. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. NICHD-NHLBI-ORD Workshop. Am J Respir Crit Care Med 2001;163:1723-9.
25. Taeusch HW, Ballard RA, Gleason CA. Avery's diseases of the newborn. Philadelphia: Elsevier, 2005.
26. Treszl A, Kocsis I, Szathmari M, et al. Genetic variants of TNF-α, IL-1beta, IL-4 receptor α-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 2003;83:241-5.
27. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
28. Morahan G, Huang D, Ymer SI, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele [correction appears in Nat Genet 2001;27:346]. Nat Genet 2001;27:218-21.
29. Prigoshin N, Tambutti M, Larriba J, et al. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol 2004;52:36-41.
30. Daher S, de Arruda Geraldes Denardi K, Blotta MH, et al. Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004;62:151-7.
31. Bont L, Heijnen CJ, Kavelaars A, et al. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001;184:355-8.
32. h1 cell responses. J Immunol 2003;170:4031-5.
33. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003;88:F209-13.
34. Hodge G, Hodge S, Haslam R, et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin Exp Immunol 2004;137:402-7.
35. Fraser J, Walls M, McGuire W. Respiratory complications of preterm birth. BMJ 2004;329:962-5.
36. Hitti J, Krohn MA, Patton DL, et al. Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol 1997;177:50-6.